Invention Grant
US08877761B2 N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors
有权
N-嘧啶-4-基-3-氨基 - 吡咯并[3,4-c]吡唑衍生物作为PKC激酶抑制剂
- Patent Title: N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors
- Patent Title (中): N-嘧啶-4-基-3-氨基 - 吡咯并[3,4-c]吡唑衍生物作为PKC激酶抑制剂
-
Application No.: US13450388Application Date: 2012-04-18
-
Publication No.: US08877761B2Publication Date: 2014-11-04
- Inventor: Hui Li , Seiji Nukui , Stephanie Anne Scales , Min Teng , Chunfeng Yin
- Applicant: Hui Li , Seiji Nukui , Stephanie Anne Scales , Min Teng , Chunfeng Yin
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A01N43/54
- IPC: A01N43/54 ; C07D403/00 ; C07D487/04
![N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors](/abs-image/US/2014/11/04/US08877761B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formulas A and B: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disase pression, virus diseases, inflammatory disorders, or diseases in which the liver is a target organ.
Public/Granted literature
- US20120202809A1 NOVEL N-PYRIMIDIN-4-YL-3-AMINO-PYRROLO[3,4-C]PYRAZOLE DERIVATIVES AS PKC KINASE INHIBITORS Public/Granted day:2012-08-09
Information query
IPC分类: